Command Palette

Search for a command to run...

VILINBIO

25.5+0.00%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Vilin Bio Med Ltd. shows no current financial metrics, indicating it is still in the early stages of development. However, its peers demonstrate a diverse range of performance metrics, with Sun Pharmaceutical Industries and Dr. Reddy's Laboratories leading in profitability and efficiency. Companies like Cipla and Mankind Pharma are also noteworthy for their solid growth and reasonable valuations, positioning them as strong contenders in the pharmaceutical sector.

Key Points
  • Vilin Bio Med Ltd. has no available financial data, suggesting it is not yet operational or lacks market presence.
  • Sun Pharmaceutical leads in profitability with a ROE of 16.13% and a PE ratio of 87.59.
  • Cipla and Dr. Reddy's are noted for their strong growth metrics and efficient operations, making them attractive investments.
  • Mankind Pharma shows significant revenue growth, indicating strong market demand.
  • Divi's Laboratories and Torrent Pharmaceuticals are struggling with high PE ratios relative to their growth.
Top Performers
Sun Pharmaceutical Industries Ltd.

Highest ROE and solid profitability metrics.

Dr. Reddy's Laboratories Ltd.

Strong growth in EPS and ROE, making it a strong competitor.

Cipla Ltd.

Good revenue growth and strong efficiency metrics.

Mankind Pharma Ltd.

Exceptional revenue growth trajectory.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.